Jackson Acquisition Company II (JACS)

NYSE: JACS · Real-Time Price · USD
10.35
0.00 (0.00%)
Jul 29, 2025, 4:00 PM - Market closed
Market Cap306.11M
Revenue (ttm)n/a
Net Income (ttm)1.14M
Shares Out 29.59M
EPS (ttm)n/a
PE Ratio267.75
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14
Open10.33
Previous Closen/a
Day's Range10.33 - 10.35
52-Week Range9.94 - 10.41
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About JACS

Jackson Acquisition Company II does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus its search for a target business in the healthcare services and healthcare technology sector. Jackson Acquisition Company II was incorporated in 2024 and is based in Alpharetta, Georgia. [Read more]

Sector Financials
IPO Date Dec 10, 2024
Country United States
Stock Exchange NYSE
Ticker Symbol JACS
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Jackson Acquisition Company II Announces Pricing of $200 Million Initial Public Offering

Jackson Acquisition Company II announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit.

8 months ago - Business Wire

Healthcare-focused SPAC Jackson Acquisition II files for a $200 million IPO

Jackson Acquisition II, a blank check company targeting healthcare, filed on Friday with the SEC to raise up to $200 million in an initial public offering.

10 months ago - Renaissance Capital

Jackson Acquisition Company II IPO Registration Document (S-1)

Jackson Acquisition Company II has filed to go public with an IPO on the New York Stock Exchange (NYSE).

10 months ago - SEC